These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26005488)

  • 1. Transcatheter atrial septal defect closure using occlutech figulla device: a two-center experience.
    Mortezaeian H; Sayadpour Zanjani K; Malakan Rad E
    J Tehran Heart Cent; 2013 Oct; 8(4):197-201. PubMed ID: 26005488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
    Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
    Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device.
    Kilic T; Ural E; Sahin T
    Tex Heart Inst J; 2015 Oct; 42(5):454-7. PubMed ID: 26504440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Performance of Amplatzer® and Occlutech® Figulla® Septal Occluders: The Pediatric Point of View. A Retrospective Study.
    Nir-David Y; Mainzer G; Tal R; Lorber A
    Isr Med Assoc J; 2017 Sep; 19(9):557-561. PubMed ID: 28971639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up.
    Snijder RJR; Renes LE; Bosshardt D; Suttorp MJ; Ten Berg JM; Post MC
    J Interv Cardiol; 2020; 2020():7136802. PubMed ID: 32140088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
    Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
    J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
    Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
    J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.
    Kenny D; Eicken A; Dähnert I; Boudjemline Y; Sievert H; Schneider MB; Gori T; Hijazi ZM;
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):316-321. PubMed ID: 30719850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
    Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
    J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transcatheter closure of secundum atrial septal defect in children].
    Gao W; Zhou AQ; Yu ZQ; Li F; Zhang YQ; Sun K; Zhong YM
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):287-90. PubMed ID: 15157392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age.
    Ammar RI; Hegazy RA
    J Invasive Cardiol; 2013 Feb; 25(2):76-9. PubMed ID: 23388225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects.
    Pac A; Polat TB; Cetin I; Oflaz MB; Balli S
    J Interv Cardiol; 2009 Dec; 22(6):489-95. PubMed ID: 19735475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.
    Roymanee S; Promphan W; Tonklang N; Wongwaitaweewong K
    Pediatr Cardiol; 2015 Jun; 36(5):935-41. PubMed ID: 25633819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: initial clinical experience.
    Ilkay E; Kaçmaz F; Ozeke O; Turan RS; Firat S; Pampal K; Ozer E; Bilgin S
    Turk Kardiyol Dern Ars; 2010 Apr; 38(3):189-93. PubMed ID: 20675996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder.
    Tada N; Mizutani Y; Matsumoto T; Sakurai M; Ootomo T
    Cardiovasc Interv Ther; 2017 Oct; 32(4):436-439. PubMed ID: 28108954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
    Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
    Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.
    Haas NA; Soetemann DB; Ates I; Baspinar O; Ditkivskyy I; Duke C; Godart F; Lorber A; Oliveira E; Onorato E; Pac F; Promphan W; Riede FT; Roymanee S; Sabiniewicz R; Shebani SO; Sievert H; Tin D; Happel CM
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):571-581. PubMed ID: 27029396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate term follow-up on transcatheter closure of atrial septal defects by Amplatzer septal occluder.
    Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A
    J Med Assoc Thai; 2000 Sep; 83(9):1045-53. PubMed ID: 11075972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.